[1]
V. V. Zlatkina, A. O. Nesen, and N. V. Demikhova, “Sodium-glucose cotransporter 2 inhibitors in the context of cardiorenal-metabolic comorbidity. Part 1: Pathophysiology and key clinical studies”, Ukr. J. Nephrol. Dial., no. 4(88), pp. 88-97, Dec. 2025.